Cibc World Market Inc. Xenon Pharmaceuticals Inc. Transaction History

Cibc World Market Inc.

$48 Billion
Q3 2024

A detailed history of Cibc World Market Inc. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 19,835 shares of XENE stock, worth $759,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,835

Previous 36,385 45.49%

Holding current value

$759,878

Previous $1.42 Million 44.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$36.12 - $43.96 $597,786 - $727,538	-16,550 Reduced 45.49%	19,835 $781,000
Q2 2024 Aug 07, 2024	SELL	$36.25 - $43.75 $33,893 - $40,906	-935 Reduced 2.51%	36,385 $1.42 Million
Q1 2024 May 13, 2024	SELL	$42.66 - $50.04 $24,401 - $28,622	-572 Reduced 1.51%	37,320 $1.61 Million
Q4 2023 Feb 13, 2024	SELL	$28.7 - $46.46 $214,676 - $347,520	-7,480 Reduced 16.49%	37,892 $1.75 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $141,764 - $164,879	4,150 Added 10.07%	45,372 $1.55 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $295,199 - $368,914	8,473 Added 25.87%	41,222 $1.59 Million
Q1 2023 May 12, 2023	BUY	$33.46 - $40.35 $341,258 - $411,529	10,199 Added 45.23%	32,749 $1.17 Million
Q4 2022 Feb 13, 2023	SELL	$33.06 - $39.43 $24,795 - $29,572	-750 Reduced 3.22%	22,550 $889,000
Q3 2022 Nov 10, 2022	SELL	$30.79 - $39.82 $726,243 - $939,234	-23,587 Reduced 50.31%	23,300 $841,000
Q2 2022 Aug 10, 2022	BUY	$25.44 - $35.16 $141,192 - $195,137	5,550 Added 13.43%	46,887 $1.43 Million
Q1 2022 May 12, 2022	SELL	$25.09 - $33.13 $208,171 - $274,879	-8,297 Reduced 16.72%	41,337 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $774,290 - $1.76 Million	49,634 New	49,634 $1.55 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Xenon Pharmaceuticals Inc. Transaction History